Misc. FDA InformationFDA For You
Consumer Health Information
Here you will find key FDA initiatives, consumer health information and partnerships, consumer health according to audience among several other helpful information.
http://www.fda.gov/consumer/default.htm
How Plants Protect Us From Disease
ScienceDaily (Apr. 27, 2009) — Everyday
foods, beverages, and spices contain healthful compounds that help us
fight harmful inflammation. And, in doing that, these
phytochemicals—the resveratrol in red wine or the catechins in green,
white and black teas, for instance—may also reduce our risk of diseases
associated with chronic inflammation, including cancer and diabetes.
At the Agricultural Research Service (ARS) Western Human Nutrition
Research Center in Davis, Calif., research molecular biologist Daniel
H. Hwang conducts studies to solve the complex puzzle of precisely how
phytochemicals fight inflammation. His investigations with cells
cultured in his laboratory have uncovered probable modes of action used
by phytochemicals from red wine, green tea, garlic, curcumin and
cinnamon.
Hwang's team has found, for example, that phytochemicals can
interfere with the normal flow of certain chemical signals or messages
sent to and from cells involved in chronic inflammation. The messages
these cells send are in the form of proteins. In particular, his group
is closely examining proteins known as TLRs (short for "Toll-Like
Receptors") and NODs (an abbreviation for the tongue-twisting
"nucleotide binding oligomerization domain containing proteins").
To Read Full Article:
http://www.sciencedaily.com/releases/2009/04/090419202029.htm
How to Evaluate Health Information on the InternetMillions of consumers are using the Internet to get health
information. And thousands of Web sites are offering health
information. Some of those sites are reliable and up-to-date; some are
not. How can you tell the good from the bad?
First, it's important to carefully consider the source of
information and then to discuss the information you find with your
health care professional. These questions and answers can help you
determine whether the health information you find on the Internet or
receive by e-mail from a Web site is likely to be reliable.
1. Who runs the Web site?
Any good health Web site should make it easy to learn who is
responsible for the site and its information. On the U.S. Food and Drug
Administration's (FDA) Web site, for example, the FDA is clearly noted
on every major page, along with a link to the site's home (main) page, www.fda.gov.
Information about who runs the site can often be found in an "About
Us" or "About This Web Site" section, and there's usually a link to
that section on the site's home page.
2. What is the purpose of the Web site?
Is the purpose of the site to inform? Is it to sell a product? Is it
to raise money? If you can tell who runs and pays for the site, this
will help you evaluate its purpose. Be cautious about sites trying to
sell a product or service.
Quackery abounds on the Web. Look for these warning signs and
remember the adage "If it sounds too good to be true, it probably is."
- Does the site promise quick, dramatic, miraculous results? Is this the only site making these claims?
-
Beware of claims that one remedy will cure a variety of illnesses, that
it is a "breakthrough," or that it relies on a "secret ingredient."
- Use caution if the site uses a sensational writing style (lots of exclamation points, for example.)
- A
health Web site for consumers should use simple language, not technical
jargon. Get a second opinion. Check more than one site.
3. What is the original source of the information on the Web site?
Always pay close attention to where the information on the site
comes from. Many health and medical Web sites post information
collected from other Web sites or sources. If the person or
organization in charge of the site did not write the material, the
original source should be clearly identified. Be careful of sites that
don't say where the information comes from.
Good sources of health information include
- Sites that end in ".gov," sponsored by the federal government, like the U.S. Department of Health and Human Services (www.hhs.gov), the FDA (www.fda.gov), the National Institutes of Health (www.nih.gov), the Centers for Disease Control and Prevention (www.cdc.gov), and the National Library of Medicine (www.nlm.nih.gov)
-
.edu sites, which are run by universities or medical schools, such as
Johns Hopkins University School of Medicine and the University of
California at Berkeley Hospital, health system, and other health care
facility sites, like the Mayo Clinic and Cleveland Clinic
-
.org sites maintained by not-for-profit groups whose focus is research
and teaching the public about specific diseases or conditions, such as
the American Diabetes Association, the American Cancer Society, and the
American Heart Association
-
Medical and scientific journals, such as The New England Journal of
Medicine and the Journal of the American Medical Association, although
these aren't written for consumers and could be hard to understand.
-
Sites whose addresses end in .com are usually commercial sites and are often selling products.
4. How is the information on the Web site documented?
In addition to identifying the original source of the material, the
site should identify the evidence on which the material is based.
Medical facts and figures should have references (such as citations of
articles in medical journals). Also, opinions or advice should be
clearly set apart from information that is "evidence-based" (that is,
based on research results).
5. How is information reviewed before it is posted on the Web site?
Health-related Web sites should give information about the medical
credentials of the people who prepare or review the material on the Web
site.
6. How current is the information on the Web site?
Web sites should be reviewed and updated on a regular basis. It is
particularly important that medical information be current, and that
the most recent update or review date be clearly posted. These dates
are usually found at the bottom of the page. Even if the information
has not changed, it is helpful to know that the site owners have
reviewed it recently to ensure that the information is still valid.
Click on a few links on the site. If there are a lot of broken links,
the site may not be kept up-to-date.
7. How does the Web site choose links to other sites?
Reliable Web sites usually have a policy about how they establish
links to other sites. Some medical Web sites take a conservative
approach and do not link to any other sites; some link to any site that
asks or pays for a link; others link only to sites that have met
certain criteria. Look for the Web site's linking policy, often found
in a section titled "About This Web Site."
To Read More of These: http://www.fda.gov/oc/opacom/evalhealthinfo.html
The Food and Drug Administration (FDA) regulates drugs and medical devices to ensure that they are safe and effective. The FDA's Buying Medicines and Medical Products Online Web page and "Buying Prescription Medicines Online: A Consumer Safety Guide" give guidance to consumers shopping for health care products online. "Tips for the Savvy Supplement User" gives advice about how to evaluate claims about dietary supplements and what to look for in Web sites selling them.
Food and Drug Administration
5600 Fishers Lane
Rockville, MD 20857
1-888-INFO-FDA (1-888-463-6332) (toll-free)
www.fda.gov
The Federal Trade Commission (FTC) enforces
consumer protection laws. As part of its mission, the FTC investigates
complaints about false or misleading health claims posted on the
Internet. The FTC's Operation Cure-All page has information to help evaluate health product claims.
Federal Trade Commission
Consumer Response Center
CRC-240
Washington, DC 20580
1-877-FTC-HELP (1-877-382-4357) (toll-free)
TTY: 1-866-653-4261 (toll-free)
www.ftc.gov
A Quick Checklist
You can use the following checklist to help make sure that the health information you are reading online can be trusted.
Source: FDA Website Management Staff
To Read Entire Article:
http://www.fda.gov/oc/opacom/evalhealthinfo.html
FDA 101: Clinical Trials and Institutional Review BoardsClinical trials test potential treatments in human volunteers to see
whether they should be approved for wider use in the general
population. A treatment could be a drug, medical device, or biologic,
such as a vaccine, blood product, or gene therapy.
Potential
treatments are studied in laboratory animals first to determine
potential toxicity before they can be tried in people. Treatments
having acceptable safety profiles and showing the most promise may then
be considered for use in clinical trials.
It is not
known whether a potential new medical treatment offers benefit to
patients until clinical research on that treatment is complete.
Clinical trials are an integral part of new product discovery and
development, and are generally required by the Food and Drug
Administration (FDA) before a new product can be brought to the market.
To Read Full Article:
http://www.fda.gov/consumer/updates/clinicaltrials041409.html
FDA Obtains Permanent Injunction Barring Two Companies from Manufacturing and Distributing Unapproved Drugs
Companies made and distributed adulterated, misbranded and unapproved drugs
The U.S. Food and Drug Administration today announced that it had
obtained a permanent injunction barring Neilgen Pharmaceuticals Inc. of
Westminster, Md., its parent company, Advent Pharmaceuticals, Inc.
(Advent), of East Windsor, N.J., and two of their officers, Bharat
Patel and Pragna Patel, from manufacturing and distributing any
unapproved, adulterated or misbranded drugs.
Both Neilgen, which does business as Unigen Pharmaceuticals Inc.
(Unigen), and Advent are contract manufacturers and distributors of
more than 25 different unapproved drug products each. The more than 50
unapproved drug products primarily include prescription cough and cold
products. The unapproved drugs manufactured by Unigen and/or Advent
include, but are not limited to:
- RE All 12 Suspension;
- BP Allergy Junior Suspension;
- PE Tann 20 mg/CP Tann 4 mg Suspension;
- BP New Allergy DM Suspension;
- D-Tann CT Tablets;
- B-Vex D Suspension;
- Histex SR; and
- Chlorpheniramine Maleate 12 mg/Pseudoephedrine HCl 120 mg LA Tablets.
The unapproved drugs manufactured by these companies have not
undergone the FDA's drug approval process, so their safety and
effectiveness have not been established and the FDA has not reviewed
the adequacy and accuracy of the directions for use and warnings on the
labeling.
To Read Full Article:
http://www.fda.gov/bbs/topics/NEWS/2009/NEW01995.html
Food Protection PlanAmerican consumers enjoy one of the safest food supplies in the
world; however, we know it can be made even safer. FDA regulates $417
billion worth of domestic food and $49 billion worth of imported food
each year—everything we eat except for meat, poultry, and some egg
products, which are regulated by the U.S. Department of Agriculture.
FDA
has developed a comprehensive Food Protection Plan to address the
changes in food sources, production, and consumption that we face in
today's world. Building upon and improving an already sound food safety
protection capability, the new plan presents a robust strategy to
protect the nation's food supply from both unintentional contamination
and deliberate attack. FDA's Food Protection Plan builds in prevention
first, then intervention, and finally, response. This new strategy will
help ensure that Americans continue to benefit from one of the safest
food supplies in the world.
To Read More:
http://www.fda.gov/oc/initiatives/advance/food.html
FDA to Review Medical Devices Marketed Prior to 1976
The FDA today announced that manufacturers of 25 types of medical
devices marketed prior to 1976 must submit safety and effectiveness
information to the agency so that it may evaluate the risk level for
each device type. Devices found by the FDA to be of high risk to
consumers will be required to undergo the agency’s most stringent
premarket review process.
These 25 device types, which are listed in the Federal Register
announcement posted today, were marketed in the U.S. prior to the
Medical Device Amendments to the Food, Drug, and Cosmetic Act of 1976.
That law authorized the FDA to review new medical devices. Today’s
announcement is the first step towards completing the review of Class
III device types predating the 1976 law, as was recommended by the U.S.
Government Accountability Office (GAO) in a January 2009 report to
Congress.
To Read More: http://www.fda.gov/bbs/topics/NEWS/2009/NEW01990.html
Insulin Pens are Not for Sharing
What are insulin pens?
Insulin
pens are pen-shaped injector devices that contain a disposable needle
and either an insulin reservoir or an insulin cartridge. The devices
typically hold enough insulin for a patient to self-administer several
doses of insulin before the reservoir or cartridge is empty.
All
insulin pens are approved only for single-patient use (one device for
only one patient). They are designed to be safe for one patient to use
one pen multiple times with a new, fresh needle for each injection.
Patients
who have been exposed to shared insulin pens are being contacted by the
two hospitals and are being offered testing for hepatitis and HIV. Some
of the potentially exposed patients have reportedly tested positive for
the hepatitis C virus, although it's not known if the virus was spread
as a result of insulin pen sharing.
FDA, the Centers
for Disease Control and Prevention, and professional organizations are
working to address infection control issues related to insulin pens.
This article appears on FDA's Consumer Health Information Web page (www.fda.gov/consumer), which features the latest updates on FDA-regulated products. Sign up for free e-mail subscriptions at www.fda.gov/consumer/consumerenews.html.
back to top
Date Posted: March 25, 2009
A Guide to Safe Use of Pain MedicineIf you've ever been treated for severe pain from surgery, an injury,
or an illness, you know just how vital pain relief medications can be.
Pain
relief treatments come in many forms and potencies, are available by
prescription or over-the-counter (OTC), and treat all sorts of physical
pain— including that brought on by chronic conditions, sudden trauma,
and cancer.
Pain relief medicines (also known as
"analgesics" and "painkillers") are regulated by the Food and Drug
Administration (FDA). Some analgesics, including opioid analgesics, act
on the body's peripheral and central nervous systems to block or
decrease sensitivity to pain. Others act by inhibiting the formation of
certain chemicals in the body.
Among the factors health care professionals consider in recommending or prescribing them are the cause and severity of the pain.
For more information regarding this topic, please visit this link:
http://www.fda.gov/consumer/updates/painmeds022309.html
Food Allergies: Reducing the Risks Food allergies can range from merely irritating to life-threatening.
Approximately 30,000 Americans go to the emergency room each year to
get treated for severe food allergies, according to the Food Allergy
and Anaphylaxis Network (FAAN). It is estimated that 150 to 200 Americans
die each year because of allergic reactions to food.
Food allergies affect about two percent of adults and four to
eight percent of children in the United States, and the number
of young people with food allergies has increased over the last decade,
according to a recent report by the Centers for Disease Control
and Prevention (CDC). Children with food allergies are more likely
to have asthma, eczema, and other types of allergies.
Some food allergies can be outgrown. Studies have shown that
the severity of food allergies can change throughout a person’s
life.
“There is no cure for food allergies,” says Stefano Luccioli,
M.D., senior medical advisor in the Food and Drug Administration’s
(FDA) Office of Food Additive Safety (OFAS). “The best way for
consumers to protect themselves is by avoiding food items that will
cause a reaction.” OFAS is part of FDA’s Center for Food
Safety and Applied Nutrition (CFSAN).
To reduce the risks from allergic reactions, FDA is working to ensure
that major allergenic ingredients in food are accurately labeled in
accordance with the Food Allergen Labeling and Consumer Protection
Act of 2004 (FALCPA). Allergenic ingredients are substances that
are capable of causing an allergic reaction.
In addition, there has been widespread use of allergen advisory
labels on products that may have allergenic ingredients that were introduced
by way of cross contact during the manufacturing process. Cross contact
occurs when a residue or other trace amount of an allergenic food is
unintentionally incorporated into another food.
Because FALPCA does not require the declaration of allergenic ingredients
introduced through cross contact, FDA is developing a long-term
strategy that will help manufacturers use voluntary allergen advisory
labeling that:
- Is not misleading
- Conveys a clear and uniform message
- Adequately informs food-allergic consumers and their caregivers
For more information regarding this topic, please visit this link:
http://www.fda.gov/consumer/updates/foodallergies012209.html
Understanding Antidepressant MedicationsDepression affects about 121 million people worldwide and is a
leading cause of disability, according to the World Health Organization
(WHO).
"In my experience as a practicing
psychiatrist, I've seen that many people with depression don't realize
that they have the condition or that it's treatable," says Mitchell
Mathis, M.D., deputy director of the Division of Psychiatry Products at
the Food and Drug Administration (FDA).
Some who
suffer from depression don't recognize the symptoms, or they attribute
them to lack of sleep or a poor diet. Others realize they are
depressed, but they feel too fatigued or ashamed to seek help.
Not all depression requires treatment with medication.
"Studies
have shown that the best way to treat a patient with the more severe
form of major depressive disorder is through both therapy and
prescribed antidepressant medication," Mathis says. "They work best in
combination with one another."
For more information regarding this topic, please visit this link:
http://www.fda.gov/consumer/updates/antidepressants010909.htmlIf you would like to see more please visit the U.S. Food and Drug Administration at:
http://www.fda.gov/